| Literature DB >> 29370174 |
Haijian Guo1,2, Xuanxuan Wang1, Tao Mao2, Xiaoning Li2, Ming Wu2, Jiaying Chen3.
Abstract
INTRODUCTION: The deleterious effects of psychosocial outcomes on diabetic patients' health have not been fully investigated yet. This study was aimed to explore how psychosocial outcomes impacted on the health status of Chinese patients with type 2 diabetes.Entities:
Mesh:
Year: 2018 PMID: 29370174 PMCID: PMC5784904 DOI: 10.1371/journal.pone.0190484
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
General characteristics of type 2 diabetes patients in eastern China (N = 1614).
| Variables | n | % |
|---|---|---|
| 1614 | 100.0 | |
| Men | 800 | 49.6 |
| Women | 814 | 50.4 |
| Mean ± SD | 53.7± 8.9 | |
| 18–40 | 141 | 8.7 |
| 41–50 | 368 | 22.8 |
| 51–60 | 677 | 41.9 |
| 61–65 | 428 | 26.5 |
| Below primary school | 294 | 18.2 |
| Primary school | 392 | 24.3 |
| Middle school | 636 | 39.4 |
| High school | 264 | 16.4 |
| College and above | 28 | 1.7 |
| Single | 39 | 2.4 |
| Married | 1511 | 93.6 |
| Other status | 64 | 4.0 |
| Income < 10000 Chinese Yuan | 249 | 15.4 |
| 10000≤ Income <40000 Chinese Yuan | 617 | 38.2 |
| 40000≤ Income < 60000 Chinese Yuan | 347 | 21.5 |
| 60000≤ Income <100000 Chinese Yuan | 263 | 16.3 |
| Income≥ 100000 Chinese Yuan | 138 | 8.6 |
Clinical characteristics of type 2 diabetes patients in eastern China (N = 1614).
| Variables | n | % |
|---|---|---|
| Hypertension | 730 | 45.2 |
| Coronary heart disease | 75 | 4.6 |
| Dyslipidemia | 358 | 22.2 |
| Stroke | 55 | 3.4 |
| Renal disease | 35 | 2.2 |
| Malignant tumor | 20 | 1.2 |
| Other comorbidity | 170 | 10.5 |
| No comorbidity | 616 | 38.2 |
| Diabetic foot | 115 | 7.1 |
| Diabetic nephropathy | 72 | 4.5 |
| Retinopathy | 348 | 21.6 |
| Neuropathy | 100 | 6.2 |
| Other complication | 15 | 0.9 |
| No complication | 1178 | 73.0 |
| Oral hypoglycemic agents | 1201 | 74.4 |
| Insulin | 264 | 16.4 |
| Other treatment | 17 | 1.1 |
| No treatment | 217 | 13.4 |
Self-reported health status, psychological well-being, diabetes distress, empowerment and healthcare provision of type 2 diabetes patients in eastern China (N = 1614).
| Variables | n | % |
|---|---|---|
| EQ VAS (Mean ± SD) | 75.8 ± 16.2 | |
| WHO-5 (Mean ± SD) | 76.2± 22.5 | |
| WHO-5 ≤ 28 | 87 | 5.4 |
| 29 ≤ WHO-5 ≤ 50 | 121 | 7.5 |
| WHO-5 > 50 | 1406 | 87.1 |
| PAID-5 (Mean ± SD) | 36.9 ± 26.9 | |
| PAID-5 < 40 | 889 | 55.1 |
| PAID-5 ≥ 40 | 725 | 44.9 |
| DES-DSF (Mean ± SD) | 53.2 ± 18.5 | |
| Healthy diet | 5.5 ± 2.2 | |
| Physical activity | 3.8 ± 2.9 | |
| SMBG | 2.2 ± 2.5 | |
| SMBG as recommended | 2.8 ± 2.7 | |
| Feet exam | 2.3 ± 2.8 | |
| Drug assumption as recommended | 5.0 ± 2.8 | |
| Smoking | ||
| Yes | 371 | 23.0 |
| No | 1243 | 77.0 |
| PACIC-DSF (Mean ± SD) | 3.3 ± 1.1 | |
EQ-VAS: EuroQol Visual Analogue Scale; WHO-5, World Health Organization Well-Being Index 5; PAID-5, Problem Areas in Diabetes Scale 5; DES-DSF, Diabetes Empowerment Scale-DAWN Short Form; SMBG, Self-Monitoring of Blood Glucose; PACIC-DSF, Patient Assessment of Chronic Illness Care-DAWN Short Form.
Impacts of general characteristics, clinical characteristics, psychological well-being, diabetes distress, empowerment, self-management and healthcare provision on self-reported health status among type 2 diabetes patients in eastern China (N = 1614).
| Variables | Model 1 | Model 2 | Model 3 | |||
|---|---|---|---|---|---|---|
| 73.852 | 0.000 | 78.444 | 0.000 | 80.025 | 0.000 | |
| Women | -0.541 | 0.533 | -0.923 | 0.261 | -0.670 | 0.462 |
| 41–50 | -3.311 | 0.040 | -1.266 | 0.414 | -1.004 | 0.509 |
| 51–60 | -4.601 | 0.002 | -1.786 | 0.228 | -2.048 | 0.158 |
| 61–65 | -3.072 | 0.061 | -0.129 | 0.936 | -0.690 | 0.661 |
| Primary school | -0.151 | 0.905 | -1.083 | 0.367 | -2.155 | 0.068 |
| Middle school | 2.640 | 0.038 | 0.780 | 0.522 | -0.287 | 0.811 |
| High school | 4.906 | 0.001 | 2.630 | 0.072 | 1.542 | 0.286 |
| College and above | 6.946 | 0.034 | 7.332 | 0.019 | 5.054 | 0.100 |
| Married | -1.247 | 0.641 | -1.056 | 0.678 | -1.673 | 0.501 |
| Other status | -2.345 | 0.475 | -2.342 | 0.452 | -2.434 | 0.424 |
| 10000≤ Income <40000 Chinese Yuan | 4.461 | 0.000 | 3.470 | 0.003 | 2.351 | 0.041 |
| 40000≤ Income < 60000 Chinese Yuan | 5.798 | 0.000 | 3.758 | 0.005 | 2.068 | 0.115 |
| 60000≤ Income <100000 Chinese Yuan | 7.386 | 0.000 | 5.064 | 0.000 | 3.440 | 0.013 |
| Income ≥ 100000 Chinese Yuan | 11.027 | 0.000 | 8.276 | 0.000 | 5.944 | 0.000 |
| Hypertension | - | - | -1.243 | 0.321 | -1.312 | 0.285 |
| Coronary heart disease | - | - | -5.437 | 0.003 | -4.336 | 0.016 |
| Dyslipidemia | - | - | -4.305 | 0.000 | -4.116 | 0.000 |
| Stroke | - | - | -7.401 | 0.000 | -6.098 | 0.003 |
| Renal disease | - | - | -9.233 | 0.001 | -8.051 | 0.003 |
| Malignant tumor | - | - | -6.696 | 0.052 | -6.347 | 0.060 |
| Other comorbidity | - | - | -4.762 | 0.002 | -4.190 | 0.005 |
| No comorbidity | - | - | -0.308 | 0.835 | -0.122 | 0.933 |
| Diabetic foot | - | - | 1.169 | 0.507 | 0.215 | 0.901 |
| Diabetic nephropathy | - | - | -0.310 | 0.883 | -0.490 | 0.812 |
| Retinopathy | - | - | -3.043 | 0.119 | -2.449 | 0.201 |
| Neuropathy | - | - | -1.845 | 0.298 | -0.035 | 0.984 |
| Other complication | - | - | -4.566 | 0.275 | -4.868 | 0.234 |
| No complication | - | - | 4.353 | 0.035 | 4.135 | 0.041 |
| Oral hypoglycemic agents | - | - | -3.645 | 0.059 | -2.212 | 0.242 |
| Insulin | - | - | -3.924 | 0.022 | -3.084 | 0.066 |
| Other treatment | - | - | -6.326 | 0.100 | -4.078 | 0.282 |
| No treatment | - | - | -2.523 | 0.258 | -2.143 | 0.349 |
| WHO-5 ≤ 28 | - | - | - | - | -9.190 | 0.000 |
| 29 ≤ WHO-5 ≤ 50 | - | - | - | - | -7.679 | 0.000 |
| PAID-5 ≥ 40 | - | - | - | - | -2.081 | 0.007 |
| DES-DSF | - | - | - | - | 0.031 | 0.176 |
| Healthy diet | - | - | - | - | -0.303 | 0.108 |
| Physical activity | - | - | - | - | 0.483 | 0.001 |
| SMBG | - | - | - | - | -0.320 | 0.156 |
| SMBG as recommended | - | - | - | - | 0.357 | 0.083 |
| Feet exam | - | - | - | - | -0.047 | 0.745 |
| Drug assumption as recommended | - | - | - | - | -0.252 | 0.144 |
| Smoking | - | - | - | - | 0.161 | 0.872 |
| PACIC-DSF | - | - | - | - | 0.250 | 0.496 |
| 0.069 | 0.181 | 0.227 | ||||
a Reference category: men.
b Reference category: age group 18–40 years.
c Reference category: below primary school.
d Reference category: single.
e Reference category: income level < 10000 RMB.
f Coded: having such comorbidity = 1; not having such comorbidity = 0.
g Coded: having no comorbidity = 1; having any one comorbidity = 0.
h Coded: having such complication = 1; not having such complication = 0.
i Coded: having no complication = 1; having any one complication = 0.
j Coded: using such treatment = 1; not using such treatment = 0.
k Coded: using no treatment = 1; using any treatment = 0.
l Reference category: WHO-5 > 50.
m Reference category: PAID-5 < 40.
n Reference category: smoking.
WHO-5, World Health Organization Well-Being Index 5; PAID-5, Problem Areas in Diabetes Scale 5; DES-DSF, Diabetes Empowerment Scale-DAWN Short Form; SMBG, Self-Monitoring of Blood Glucose; PACIC-DSF, Patient Assessment of Chronic Illness Care-DAWN Short Form.